Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Ibuprofen Extrudate vs Lysinate and Standard Tablet
NCT02183012Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2002
- Primary completion
- Oct 2002
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of ibuprofen in pain (6 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the concentration-time curve from zero to infinity at 24 hours, Maximum observed concentration at 24 hours and 1 more. Started Aug 2002; status: completed.
02
Drugs
ibuprofen
03
Conditions
pain
Beyond the preview
Go deeper on NCT02183012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02183012.